Dopamine receptor stimulating agonists in the treatment of Parkinson's disease

Y Agid; G Barroche; A M Bonnet; F Javoy-Agid; G Kato; F Lhermitte; P Pollak; J L Signoret

Dopamine receptor stimulating agonists in the treatment of Parkinson's disease

Biomedicine. 1979 Jun;30(2):67-71.

Authors

Y Agid, G Barroche, A M Bonnet, F Javoy-Agid, G Kato, F Lhermitte, P Pollak, J L Signoret

PMID: 383169

Abstract

In this article, the clinical actions of the principal dopamine receptor stimulating agents (apomorphine and its derivatives; piribedil, rye-ergot derivatives) are discussed on the basis of their biochemical and pharmacological properties.

Publication types

Review

MeSH terms

Apomorphine / analogs & derivatives
Apomorphine / therapeutic use
Bromocriptine / therapeutic use
Humans
Levodopa / therapeutic use
Parkinson Disease / drug therapy*
Parkinson Disease / physiopathology
Piribedil / therapeutic use
Receptors, Dopamine / physiology*

Substances

Receptors, Dopamine
Bromocriptine
Levodopa
Piribedil
Apomorphine